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Recovery from Muscarinic Modulation
of M Current Channels Requires
Phosphatidylinositol 4,5-Bisphosphate Synthesis
inositol-1,4,5-trisphosphate (IP3) or diacylglycerol or
both. However, repeated tests of IP3, Ca2, and protein
kinase C as candidate messengers have proven nega-
tive (Bosma and Hille, 1989; Beech et al., 1991; Cruz-
blanca et al., 1998; del Rı´o et al., 1999; Shapiro et al.,
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2000). An alternative and more recent hypothesis is that
Summary a decrease in the concentration of the membrane lipid
phosphatidylinositol-4,5-bisphosphate (PIP2) is the sig-
Suppression of M current channels by muscarinic re- nal that depresses IM. Several ion channels open in the
ceptors enhances neuronal excitability. Little is known presence of PIP2 and close when PIP2 is depleted from
about the molecular mechanism of this inhibition ex- the membrane (Huang et al., 1998; Shyng and Nichols,
cept the requirement for a specific G protein and the 1998; Sui et al., 1998; Hilgemann et al., 2001). After PIP2
involvement of an unidentified diffusible second mes- is hydrolyzed by PLC, the action of several lipid kinases
senger. We demonstrate here that intracellular ATP is using ATP is required to resynthesize it. This paper tests
required for recovery of KCNQ2/KCNQ3 current from the need for ATP and lipid kinases in the recovery from
muscarinic suppression, with an EC50 of0.5 mM. Sub- the muscarinic inhibition of IM.
stitution of nonhydrolyzable ATP analogs for ATP The role of intracellular ATP in the regulation of IM
slowed or prevented recovery. ADPS but not ADP remains confusing. Pfaffinger et al. (1988) found that IM
also prevented the recovery. Receptor-mediated inhi- fell to below 20% of its initial value after 8 min of dialysis
bition was irreversible when recycling of agonist-sen- with ATP-free whole-cell pipette solutions, and Toki-
sitive pools of phosphatidylinositol-4,5-bisphosphate masa and Akasu (1990) reported a similar fall after 15
(PIP2) was blocked by lipid kinase inhibitors. Lipid min of dialysis with adenylyl-imidodiphosphate (AMP-
phosphorylation by PI 4-kinase is required for recovery PNP) replacing all ATP. In contrast, Simmons et al. (1990)
from muscarinic modulation of M current. found that IM remained above 80% of its initial value
with a similar AMP-PNP pipette solution, and others
Introduction suggested that intracellular ATP levels did not affect
rundown of IM (Chen and Smith, 1992). More recently,
The M current (IM) is a voltage- and time-dependent Simmons and Schneider (1998) found that metabolic
potassium current first described in sympathetic neu- substrates such as glucose and pyruvate in the extracel-
rons (Brown and Adams, 1980) and subsequently ob- lular solution allow IM to be maintained in the absence
served in several other neurons, including hippocampal of added ATP. These studies emphasized rundown of
and cortical pyramidal cells (for review, see Marrion, current. Is there also a role of ATP in receptor-mediated
1997). The IM is a subthreshold voltage-gated K current modulation?
that stabilizes the membrane potential and controls neu- Here we coexpress channel subunits KCNQ2 and
ronal excitability; its receptor-mediated suppression in- KCNQ3 with M1 muscarinic receptors to reconstitute mod-creases responses to excitatory synaptic inputs (Jones ulation of IM in a heterologous expression system (Shapiroet al., 1995; Wang and McKinnon, 1995). Agonists for et al., 2000). To verify that our conclusions apply to native
gonadotropin-releasing hormone receptors, angioten-
neurons, we also study modulation of endogenous IM insin II receptors, purinergic receptors, substance P re-
sympathetic neurons. Our emphasis is on recovery from
ceptors, bradykinin receptors, and muscarinic M1 recep- muscarinic inhibition. We demonstrate that the recoverytors all inhibit IM (Shapiro et al., 1994a; Simmons et al., of the IM from muscarinic inhibition is tightly dependent1994; Choi and Lovinger, 1996; Cruzblanca et al., 1998),
upon the cytosolic level of ATP—even though ATP levelsincreasing neuronal excitability.
do not affect the induction of muscarinic inhibition. WeThe precise signal transduction mechanism for the
also provide evidence that a membrane lipid kinase,decrease of IM is not known. The data clearly indicate
PI 4-kinase, but not PI 3-kinase or protein kinases, isthat inhibition of IM by these receptors follows activation
required in this ATP-mediated recovery of IM.of an NEM- and pertussis toxin-insensitive G protein of
the Gq/11 class (Pfaffinger et al., 1988; Caulfield et al.,
Results1994; Shapiro et al., 1994b; Haley et al., 1998); it involves
a diffusible cytoplasmic signal (Selyanko et al., 1992;
Muscarinic Suppression and RecoveryMarrion, 1993) and is interrupted when cytoplasmic cal-
of IM via PLCcium is held below normal levels (Beech et al., 1991).
Cotransfection of the plasmids for the two channel sub-The same signal may modulate L- and N-type Ca2 chan-
units KCNQ2 and KCNQ3 in tsA cells yields slowly acti-nels in sympathetic neurons (Hille, 1994; Shapiro et al.,
vating and deactivating currents with IM-like voltage de-1994a). Its identity is a major question in this field. Know-
pendence, kinetics, and pharmacology that can being that the G protein Gq/11 normally activates phospholi-
suppressed by the application of the muscarinic agonistpase C (PLC), a natural suggestion would be that the
diffusible message is a product generated by PLC, either oxotremorine-M (oxo-M) (Shapiro et al., 2000). Figure 1A
shows a family of currents over a range of test potentials
before and during oxo-M application, and after washout1Correspondence: hille@u.washington.edu
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occurred with a mean exponential time constant  of
7.5  0.8 s—slower than the measured solution ex-
change time (2.4 s). The suppression is mediated by the
M1 muscarinic receptors since it was almost completely
abolished when oxo-M was applied in the presence of
10 M pirenzepine and it was absent when cells were
not cotransfected with the receptor (n  3) (data not
shown). Linopirdine (30 M), a selective blocker of IM
(Lamas et al., 1997), completely inhibited the expressed
current (Figure 1B). The slow recovery after muscarinic
suppression of the current followed an exponential time
course with a time constant  of 217  18 s (Figure
1C). The mean recovery of the current from muscarinic
suppression in these experiments was to 77%  9%
(n  17) of the preceding level, measured 10 min after
washout of oxo-M. Figure 2A shows the muscarinic
modulation of IM in superior cervical ganglion (SCG) neu-
rons after overnight culture. IM was strongly suppressed
by 10 M oxo-M in the same time as for tsA cells (induc-
tion  of 7.8  1.3 s), but the recovery was twice as fast
( of 108  23 s [n  7]).
Muscarinic M1 receptors usually couple via the G pro-
teins Gq/11 to PLC. To test whether activation of PLC is
required for suppression of IM, we compared the actions
of a PLC inhibitor U73122 with those of an inactive ana-
log. For both tsA cells and SCG neurons, we found
that 1 M U73122 is relatively ineffective at blocking
muscarinic suppression (although it did slow the induc-
tion), but 3 M had a strong effect. We did not study
higher concentrations since they reduced the size of IM
considerably. The inactive control compound U73343
had only a weak effect. Figure 2B shows experiments
with SCG neurons incubated with U73122 or U73343 for
5 min after breakthrough, and Figure 2C summarizes
the experiments on both cell types. We conclude that
the pathway for muscarinic receptor-mediated inhibition
of IM and KCNQ2/KCNQ3 channels requires the activa-
tion of PLC. The small increase of IM with 1 M U73122
may indicate that there is some tonic activity of PLC that
depresses current even without receptor stimulation.
Figure 1. Muscarinic Modulation of KCNQ2/KCNQ3 Channels in tsA
Intracellular ATP Is Required for RecoveryCells
from Muscarinic Inhibition(A) Families of current elicited by voltage steps from 80 to 40 mV,
in 10 mV intervals, before and during the application of 10 M oxo-M, To explore a role for ATP in recovery from muscarinic
and after washout of oxo-M. Holding potential 70 mV. Inset shows inhibition, we stimulated transfected tsA cells several
the pulse protocol. (B) Reversible regulation of current at 20 mV times with oxo-M (10 M) in the presence of various
by short muscarinic stimulation. Oxo-M and linopirdine (30M) were concentrations of ATP in the pipette solution. When thebath-applied as marked. Pulses to 60 mV were given every 4 s,
pipette contained 3 mM ATP, successive 20 s exposuresand points are plotted at the same intervals. Inset shows the current
to oxo-M repeatedly suppressed the current with a simi-waveforms. Dashed line in the current traces is the zero-current
level. (C) Recovery from the muscarinic suppression. Oxo-M was lar induction time course (  7.2 s) (Figure 3A). The
applied for 20 s. Recovery of the current was calculated as a per- recovery was strong, although never quite complete (cf.
centage of the preapplication level. n  17, mean  SEM. Figure 3D). Closer inspection shows that the channel
recovery from muscarinic inhibition slowed with re-
peated stimulation of the cell (Figure 3B). The recoveryof the oxo-M. Here cells were held at 70 mV, and
voltage steps given from 80 to 40 mV evoked the K rate differed among cells, but it was always slightly
slower in the second and the third stimulations (n  5).current. Oxo-M suppresses the outward KCNQ2/KCNQ3
current at all voltages. The 10 M concentration of When the ATP in the pipette was decreased to 0.3 mM,
the extent of channel recovery was dramatically dimin-oxo-M used throughout this paper is supramaximal.
We first review the basic parameters of inhibition and ished even in the first agonist exposure (Figure 3C). As
summarized in Figure 3D, the recovery with 0.3 mMrecovery. Figure 1B shows the time course of oxo-M
effects, now measuring KCNQ2/KCNQ3 current as we ATP was significantly less than with 3 mM ATP and
diminished further in the subsequent stimulations. Al-do in the rest of paper as the steady holding current
at 20 mV. Induction of receptor-mediated inhibition though it affected recovery from inhibition, the reduction
Phosphorylation and Recovery from Modulation
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Figure 2. Muscarinic Modulation of IM via
PLC
(A) Currents in SCG neurons elicited by the
pulse protocol shown below, before (control)
and during application of 10 M oxo-M
(Oxo-M). Left: typical time-dependent modu-
lation of the IM by bath application of oxo-M
for 20 s. The amplitude was measured as the
difference between the current 10–20 ms
after the beginning of the voltage step (Y1)
and the current at the end of the step (Y2).
Membrane capacitance, 38 pF. (B) Effects of
aminosteroids on muscarinic modulation of
IM in SCG neurons. Five minutes after amino-
steroid treatment began, oxo-M was added
for 20 s. (C) Summary of effects of aminoste-
roids on muscarinic inhibition in SCG neurons
and tsA cells.
of intracellular ATP concentration did not slow or dimin- without 3 mM ATP in the pipette solution, respectively.
Thus, the decrease of channel recovery with 0.3 mMish the induction of inhibition by oxo-M (Figure 3E).
In order to check whether the depression of recovery ATP pipette solution is not due to a more rapid rundown
of the channels but to ATP dependence of recovery fromfrom muscarinic suppression might represent a rapid
rundown of the channel in low intracellular ATP concen- the muscarinic receptor-mediated suppression.
trations, we investigated the effect of cytosolic ATP on
the maintenance of KCNQ2/KCNQ3 currents. As is sum- Nonhydrolyzable ATP Analogs Exert Dominant-
Negative Effects on Recoverymarized in Figure 3F, there was no significant difference
in the spontaneous slow loss of channel activity (run- We next tested whether the hydrolysis of phosphate
groups from ATP is needed for recovery. We replaceddown) between control and ATP-deficient cells; the
mean channel activity fell to 42%  7% (n  8) and ATP with nonhydrolyzable ATP analogs in the pipette
solution. Both AMP-PNP and adenylylmethylene diphos-48% 5% (n 7) of the initial level after 30 min with and
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Figure 3. Importance of Intracellular ATP for
Recovery of KCNQ2/KCNQ3 Currents from
Muscarinic Suppression
(A) Time course of current at 20 mV with 3
mM ATP in the pipette solution. Oxo-M was
bath-applied four times for 20 s. Inset shows
current traces from before each oxo-M expo-
sure. Typical traces from more than five ex-
periments. (B) Time course of recovery from
the repetitive stimulations with oxo-M shown
in (A) The time to half recovery was 133 s
after the first oxo-M exposure (1), 160 s after
the second (2), and 197 s after the third (3).
(C) The same kind of experiment as in (A)
except with 0.3 mM ATP. The plot is typical
of five experiments. (D) Summary of recovery
from repeated oxo-M stimulations in five ex-
periments. *p  0.01, compared with 3 mM
ATP. (E) Time constant () for current inhibi-
tion in repeated muscarinic stimulations with
pipette solutions containing 3 mM or 0.3 mM
ATP. (F) Time course of rundown of KCNQ2/
KCNQ3 current with and without intracellular
ATP. Measurements started 3 min after
breaking through to whole-cell recording.
Solid line, with 3 mM ATP (n  7); dotted line,
without ATP (n  8). Linopirdine (30 M) was
added at the end of experiments.
phonate (AMP-PCP) are expected to be competitive in- recovery observed with 1 mM ATP was inhibited by
addition of AMP-PNP or AMP-PCP in a concentration-hibitors of reactions requiring hydrolyzable ATP. In the
experiments shown in Figures 4A–4C, the pipette solu- dependent manner. In all cases, the recovery was to
less than 10% of the preceding level when 3 mM AMP-tion contained different mole fractions of AMP-PNP and
ATP. With a lowered mole fraction of hydrolyzable ATP PNP or AMP-PCP was added along with 1 mM ATP in
the pipette. These results indicate that nonhydrolyzablein the pipette, the rate and extent of muscarinic suppres-
sion of KCNQ2/KCNQ3 current were not affected but forms of adenine nucleotides act as inhibitors of the
ATP-mediated channel recovery and that hydrolysis ofthe recovery was greatly reduced (see also Figure 4G).
By 7 min after washout of oxo-M, the current had recov- ATP and probably a phosphorylation reaction with a
relatively low affinity for ATP are required for the recov-ered to only 32%  7% of the preceding level with 2
mM ATP plus 1 mM AMP-PNP and to 12%  5% with ery of KCNQ2/KCNQ3 and M current channels.
AMP-PNP is commercially available only as the lithium1 mM ATP plus 2 mM AMP-PNP, significantly lower than
the control 72%  9% (p  0.01) (Figure 4F). Moreover, salt. Since millimolar Li disrupts phosphoinositide turn-
over during the stimulation of PLC-coupled receptorsin the presence of 4 mM AMP-PNP or AMP-PCP without
added ATP, there was almost no recovery from oxo-M (Jenkinson et al., 1994), we needed to control for effects
of Li. However, the recovery of the channel was not(Figures 4D–4F). Evidently, hydrolyzable ATP is prereq-
uisite for the recovery of KCNQ2/KCNQ3 channels from much affected by Li alone. When the pipette solution
contained 3 mM ATP and 16 mM LiCl, recovery was tomuscarinic suppression. Similarly, in SCG neurons,
complete substitution of AMP-PNP for ATP blocked the 65%  8% (n  4, p  0.1 versus control) 7 min after
the washout of oxo-M (data not shown). Furthermore,recovery from muscarinic suppression without affecting
the induction or rate of inhibition (Figures 4H and 4I). AMP-PCP, a sodium salt, blocked the recovery as much
as AMP-PNP did. Therefore, we presumed that the inhi-Figure 4J summarizes the effects of AMP-PNP and
AMP-PCP on channel recovery in tsA cells in the pres- bition from muscarinic suppression is due to the nonhy-
drolyzable ATP analog itself.ence of a constant concentration of 1 mM ATP. The
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Figure 4. Nonhydrolyzable ATP Analogs Slow Recovery
Different combinations of ATP, AMP-PNP, and AMP-PCP were included in the pipette solution to test the ATP dependence of recovery from
muscarinic suppression. All experiments except (H) and (I) are with tsA cells. The pipette solutions contained: (A) 3 mM ATP without AMP-
PNP, (B) 2 mM ATP and 1 mM AMP-PNP, (C) 1 mM ATP and 2 mM AMP-PNP, or (D and E) 4 mM AMP-PNP or 4 mM AMP-PCP and no ATP.
The insets show selected current traces. (F) Summary of recovery from inhibition under the various conditions of (A)–(E), measured 7 min after
washout of oxo-M and normalized to the value before the stimulation. (G) Time constant () of muscarinic inhibition with different combinations
of ATP and ATP analogs in pipette solution. (H) Modulation of IM in SCG neurons. The pipette solution contained 3 mM ATP or 4 mM AMP-
PNP. Oxo-M was applied for 20 s as indicated. Inset shows selected current traces. IM was taken 8–10 min after pipette breakthrough. (I)
Summary of time constant () and recovery from inhibition with ATP and AMP-PNP in pipette solution. Recovery was measured 5 min after
washout of oxo-M and normalized to the value before the stimulation. (J) AMP-PNP and AMP-PCP reduce ATP-mediated channel recovery.
The pipette contained 1 mM ATP and the listed analogs. The control had only 1 mM ATP.
ADP with Glucose Supports Recovery ATP (Simmons and Schneider, 1998). Thus it is possible
that ATP can be resynthesized from precursors by en-of KCNQ2/KCNQ3 Currents
In bullfrog sympathetic ganglion cells, extracellular glu- ergy metabolism during our recordings (our bathing so-
lution contains 8 mM glucose). We tested this possibilitycose can help to maintain IM in the absence of pipette
Neuron
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Figure 5. ADP Substitutes for ATP
Currents were recorded after waiting at least
5 min from breakthrough to allow for dialysis
of nucleotides. (A) Current at 20 mV re-
corded with 3 mM ADP instead of ATP in a
bath with or without 8 mM glucose. Oxo-M
was applied as indicated. (B) Dose-response
relation for recovery with ATP or ADP in the
pipette. Mean of four to seven experiments.
(C) Currents at 20 mV with 2 mM ADP	S or
2 mM ADP	S and 1 mM ADP. Oxo-M was
applied as indicated. (D) Summary of channel
recovery with combinations of ADP	S and
ADP, measured 7 min after washout of oxo-M
and normalized to the value at the beginning
of the stimulation. *p  0.01, compared with
2 mM ADP	S.
by totally replacing ATP with ADP in the pipette solution. from ADP suffices to maintain channel activity and also
can support recovery from muscarinic inhibition.Figure 5A shows that KCNQ2/KCNQ3 current still recov-
ers well from muscarinic inhibition with 3 mM ADP in
the pipette. The concentration-dependent effects of G Protein Activity Is Not Needed for Recovery
from Muscarinic SuppressionADP and ATP on the recovery of the current are virtually
identical (Figure 5B). About 0.5 mM of either nucleotide We then tested if GTP has a role in recovery, using tsA
cells dialyzed with various GTP or GDP analogs. Sincepermits half-maximal recovery. Substitution of ADP
changed neither the oxo-M-induced suppression nor some of the analogs slowed inhibition, we used longer
agonist exposures, 5 min in oxo-M. With the standardthe rundown of the KCNQ2/KCNQ3 channels. Extracel-
lular glucose is essential for this action of ADP. The pipette solution, the KCNQ2/KCNQ3 current was sup-
pressed by oxo-M throughout the 5 min exposure torecovery with 3 mM ADP is no better than with ADP- and
ATP-free pipette solutions if the extracellular glucose is oxo-M (Figure 6A, top). Thus, muscarinic receptors re-
main active for the full time without desensitizing (Suhremoved (Figures 5A, lower panel and 5B), and sponta-
neous reduction is accelerated. Another pathway for and Kim, 1995; Willars et al., 1998). Within 7 min after
washout of oxo-M, the current recovered to 52%  7%synthesis of ATP from ATP uses adenylate kinase (2ADP→
ATP AMP). However, addition of the adenylate kinase of the preagonist value. The GDP analog guanosine 5
-
O-(2-thiodiphosphate) (GDP	S) generally acts as a com-inhibitor P1,P5-di(adenosine-5
) pentaphosphate Ap5A
(200 M) to the pipette solution did not alter the ADP- petitive antagonist of GTP binding to G proteins. Substi-
tution of the intracellular GTP by GDP	S slowed themediated recovery of the KCNQ2/KCNQ3 current
(67%  8%, n  7). reduction of muscarinic inhibition 6-fold (  45.8 3.6 s,
n6) and decreased the maximum suppression of currentTo further examine whether the efficacy of ADP is due
to ATP synthesis from ADP, we used adenosine 5
-O- (Figure 6A, bottom). However, including GDP	S did not
hinder the recovery of the channel; mean recovery was(2-thiodiphosphate) (ADP	S), which, being a poor sub-
strate for phosphorylation by kinases, is a competitive to 60%  4% with 0.03 mM GTP plus 0.7 mM GDP	S
and to 44%  12% with 1 mM GDP	S (Figure 6B). Ininhibitor of ATP synthesis. With an ATP-free pipette solu-
tion containing 2 mM ADP	S, there was no recovery at contrast, in cells dialyzed with the nonhydrolyzable GTP
analogs guanosine 5
-O-(3-thiotriphosphate) (GTPS) orall (Figure 5C, upper). Partial recovery could be restored
by including ADP along with ADP	S (Figures 5C, lower guanylyl-imidodiphosphate (GMP-PNP), the current did
not recover after the 5 min stimulation with oxo-M (Fig-and 5D). However, ADP was significantly less effective
with ADP	S than without. Apparently, ATP synthesis ure 6B). Presumably, with these analogs, activity of the
Phosphorylation and Recovery from Modulation
513
Figure 6. GTP Analogs Slow Induction of
Muscarinic Modulation
(A) Current with the standard 0.1 mM GTP
(top) or 1 mM GDP	S in the pipette (bottom).
Oxo-M applied for 5 min as indicated. (B)
Summary of recovery with different GTP ana-
logs. Number of experiments given in paren-
theses. (C) Currents with 1 mM of ATP and
GDP	S without (top) or with (bottom) 4 mM
AMP-PNP. Oxo-M was applied for 3 min. (D)
Summary of seven experiments like that in
(C), showing current before (a), during (b), and
7 min after (c) oxo-M. Pipette solutions con-
tain 1 mM GDP	S instead of GTP. *p  0.01,
compared with 1 mM ATP alone.
G proteins cannot be shut off by the normal GTPase the effects of various kinase inhibitors. In a variety of
cells, the receptor-mediated activation of PLC depletesactivity. Thus, although intracellular GTP is required for
receptor-mediated channel inhibition, the recovery is PIP2 in the plasma membrane, and the replenishment of
PIP2 requires ATP and lipid kinases, such as PI 4-kinase.not dependent on GTP and G proteins.
The recovery of current from muscarinic suppression Therefore, using the inhibitors wortmannin and phenyl-
arsine oxide (PAO) (Nakanishi et al., 1995; Meyers andwas analyzed using ATP analogs in the presence of
1 mM GDP	S instead of GTP to further exclude the Cantley, 1997; Varnai and Balla, 1998), we asked if inhibi-
tion of PI 4-kinase might affect recovery of the KCNQ2/involvement of GTP and G proteins in recovery. As
shown in Figure 6C, when we decreased the concentra- KCNQ3 current from muscarinic inhibition. Many recent
studies report that wortmannin inhibits the replen-tion of hydrolyzable ATP in the pipette to 1 mM, the
extent of recovery was not significantly affected. However, ishment of PIP2 after muscarinic receptor-mediated
depletion (Willars et al., 1998; Sorensen et al., 1998; Xiethe addition of 4 mM of the nonhydrolyzable ATP analog
AMP-PNP along with 1 mM ATP dramatically blocked et al., 1999). As shown in Figure 7A, when we applied
wortmannin in the bath, the recovery of current wasthe recovery. Relative current 7 min after oxo-M washout
was only 23%  7% (n  7) with 1 mM ATP plus 4 mM clearly slowed and reduced in a concentration-depen-
dent manner; the current recovered to only 18%  7%AMP-PNP, significantly lower than the control group
58%  6% (n  7, p  0.01) (Figure 6D). Similarly, 4 at 10 M and to 2%  3% at 50 M wortmannin (Figure
7B). In tsA cells treated with 50 M wortmannin, themM AMP-PCP with 1 mM ATP suppressed the recovery
in the presence of 1 mM GDP	S (data not shown). Thus, current no longer recovered, even 10 min after the wash-
out of wortmannin (data not shown), consistent withas before, hydrolyzable ATP is important for the recovery
from muscarinic suppression but not for the induction previous reports that the inhibitory effect of wortmannin
is persistent (Nakanishi et al., 1995). In SCG neurons,of suppression, whereas GTP is exclusively involved in
the induction of receptor-mediated suppression and is the actions of wortmannin were similar and recovery
was almost completely blocked by 50 M wortmanninnot involved in recovery.
(Figures 7C and 7D). Despite its profound effect on re-
covery, wortmannin did not affect the inhibition of IM orInhibition of the Resynthesis of PIP2 Prevents
Recovery of IM of KCNQ2/KCNQ3 current during oxo-M application.
PAO, an arsenical that blocks the formation of PIP2The need for hydrolyzable ATP suggests that a kinase
mediates recovery. To test this hypothesis, we examined from PI by inhibiting PI 4-kinase (Wiedemann et al., 1996;
Neuron
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Figure 7. Recovery from Muscarinic Suppression with Wortmannin and Other Kinase Inhibitors
(A) Inhibition and recovery of currents in tsA cells treated with 1, 10, or 50 M wortmannin. Three minutes after wortmannin treatment began,
oxo-M was added for 20 s. (B) Summary of experiments like those in (A). (C) Modulation of IM with wortmannin in SCG neurons. Experiments
done as in (A). (D) Summary of experiments like those in (C). (E) Inhibition and recovery in tsA cells treated with 10 or 30 M PAO in the
absence or presence of 1 mM DTT. (F) Summary of effects of PAO on inhibition and recovery of current. Mean of five to ten experiments. (G)
Lack of effect of PI 3-kinase on channel recovery. Left, Muscarinic modulation and recovery in cells transfected with a dominant-negative PI
3-kinase regulatory subunit plasmid DN p85 (1 g). Right, Recovery in cells preincubated with 100 M LY 294002 for 1 hr and studied in the
presence of LY 294002. (H) Lack of effect of MLCK inhibition on channel recovery. Recovery in cells preincubated with 10 M of the MLCK
inhibitor ML-7 for 30 min and studied in the presence of ML-7. Applications of 30 M linopirdine are marked. Preincubation with LY 294002,
ML-7, ML-9, or the protein kinase inhibitors did not change the initial KCNQ2/KCNQ3 current recorded at 20 mV. (I) Summary of recovery
in the presence of the kinase inhibitors. Includes cells preincubated with 40 M ML-9 or 2 M KN-62 and 50 M of PD 98059, inhibitors for
CaMK and MEK, for 30 min and then stimulated with oxo-M for 20 s in the presence of the inhibitors. Number of cells in parentheses.
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Table 1. Effects of Kinase Inhibitors on Recovery of KCNQ2/KCNQ3 Channles from Muscarinic Suppression
Recovery
Kinase Inhibitor (Dose) Affected Kinase (% of Initial) n
None None 72  6 20
Wortmannin (10 M) PI 3- and 4-kinase, MLCK 18  7* 12
K-252a (10 M) MLCK, PKC, PKA 75  7 5
Bisindolylmaleimide I (3 M) PKC 68  6 4
H-89 (10 M) PKA 64  5 4
KN-62 (2 M) CaMK 66  8 5
PD 98059 (50 M) MEK 74  6 5
SB 203580 (10 M) ERK 71  5 4
AG213 (100 M) Tyrosine kinase 67  4 5
Genistein (50 M) Tyrosine kinase 70  5 4
Cells were preincubated with SB 203580, AG213, and genistein for 1 hr, KN-62 and K-252a for 30 min, or H-89 and bisindolylmaleimide I for
5 min. The channel recovery was measured 7 min after washout of oxo-M and was normalized to the value at the beginning of the stimulation.
None, Untreated control. *p  0.01, compared with the control.
Varnai and Balla, 1998; Sorensen et al., 1998), also pre- clearly blocked recovery. In contrast, no significant dif-
ferences were found between the control group and thevented the recovery of the KCNQ2/KCNQ3 current after
muscarinic inhibition. As shown in Figure 7E, PAO signif- groups treated with the serine-threonine protein kinase
inhibitors bisindolylmaleimide I and H-89. The same wasicantly blocked the recovery of current at 10 M (23%
4%, n  5), and almost completely blocked it at 30 M the case for KN-62, an inhibitor of Ca2/calmodulin-
dependent kinase; AG213 and genistein, inhibitors of(2%  4%, n  10). This inhibitory effect of PAO was
prevented by addition of vicinal dithiol sulfhydryl re- tyrosine kinases; and SB 203580 and PD 98059, inhibi-
tors of extracellular signal-regulated kinase (ERK) andagents to the PAO solution: dithiothreitol (DTT) gave
full prevention and 2,3-dimercaptopropanol (BAL) gave MEK, respectively. This pharmacological profile points
to PI 4-kinase as the relevant kinase for recovery ofpartial prevention (Figures 7E and 7F). POA forms stable
inactive complexes with DTT and BAL (Schaefer et al., KCNQ2/KCNQ3 current.
Because of ongoing endogenous hydrolysis of PIP2,1994). The induction of muscarinic inhibition was not
affected by PAO (Figure 7F). irreversible inhibition of PI 4-kinase by wortmannin or
PAO will deplete PIP2 from unstimulated cells (Wiede-Wortmannin also inhibits PI 3-kinase and myosin light
chain kinase (MLCK) (Okada et al., 1994; Nakanishi et mann et al., 1996; Willars et al., 1998). Therefore, we
asked if long treatments with the kinase inhibitors de-al., 1995). Therefore, we needed to compare the effects
of wortmannin with those of other kinase inhibitors. In crease channel activity without application of agonist.
As shown in Figure 8, during 13 min exposures to wort-experiments illustrated in Figure 7G and summarized in
Figure 7I, the recovery of KCNQ2/KCNQ3 current was mannin or PAO, the KCNQ2/KCNQ3 current ran down
more quickly than in control. The faster rundown wasnot significantly different from the control in cells cotrans-
fected with a dominant-negative PI 3-kinase regulatory evident in 10 M wortmannin (Figure 8B) and dramatic
in 50 M wortmannin (Figure 8C) and 30M PAO (Figuresubunit (DN p85) (Dhand et al., 1994; Poser et al., 2000)
or treated with the PI 3-kinase inhibitor LY 294002 8D). Addition of DTT blocked the effect of PAO on run-
down (Figure 8E). As before with wortmannin- and PAO-(Vlahos et al., 1994). In addition, treatment of cells with
the MLCK inhibitors ML-7 (Figures 7H and 7I) (Watanabe treated cells, application of oxo-M inhibited current rap-
idly, and there was little recovery. These results areet al., 1998; Aromolaran et al., 2000) and ML-9 (Wata-
nabe et al., 1998; Samizo et al., 1999) had little effect consistent with the hypothesis that the amplitude of
the KCNQ2/KCNQ3 current mirrors the PIP2 level in theon the recovery. In these experiments, the cells were
preincubated with the MLCK inhibitors for 30 min. The membrane.
presence of large currents upon subsequent break-
through showed that maintenance of KCNQ2/KCNQ3 Discussion
currents does not require this kinase. MLCK can be
activated by two different pathways: a Ca2/calmodulin- This paper distinguishes the induction of muscarinic
inhibition of IM from the recovery. In broad strokes, wedependent kinase-mediated pathway and a mitogen-
activated protein kinase kinase (MEK)-mediated path- find that GTP is needed only for the induction of inhibi-
tion, and ATP hydrolysis is needed only for the recovery.way (Pfitzer, 2001). However, when we treated the cells
with a mixture of the selective inhibitors for these path- Some lipid kinase inhibitors do not change the induction,
but block the recovery. Many other kinase inhibitors doways, KN-62 and PD 98059, there was no significant
difference in the recovery compared to the control not affect recovery.
(72%  4%, n  8) (Figure 7I) and no change in the
muscarinic inhibition or the maintenance of KCNQ2/ Observations with Nucleotides and Recovery
In our work, reducing the ATP in the pipette from 3 mMKCNQ3 current.
Table 1 compares the magnitudes of recovery of cur- to 0.3 mM reduces recovery from brief muscarinic inhibi-
tion in a cumulative manner so that after three exposuresrent from muscarinic inhibition in the presence of various
kinase inhibitors. The application of 10 M wortmannin to oxo-M there is no recovery. Replacing some of the
Neuron
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Figure 8. Wortmannin and PAO Accelerate
Rundown of KCNQ2/KCNQ3 Current
Rundown of currents with 1 M (A), 10 M
(B), 50 M (C) of wortmannin, or 30 M of
PAO without (D) and with (E) 1 mM DTT in the
bath (left; solid line). To show the effect of
wortmannin or PAO on the muscarinic modu-
lation, oxo-M was applied for 20 s to a single
cell 3 or 4 min after starting treatment with
wortmannin or PAO treatment (right; circles).
Dotted line shows the spontaneous rundown
of the current taken from Figure 3F. (F) Sum-
mary of the relative current 13 min after appli-
cation of inhibitors. *p 0.01, compared with
30 M PAO alone.
ATP with nonhydrolyzable analogs or just adding the “normal” spontaneous rundown of the channels. Sec-
ond, it is possible that rundown and slowed recoverynonhydrolyzable analogs to a constant ATP concentra-
tion slows recovery or even stops it. Pfaffinger et al. reflect the same process. If so, rundown might be a tonic
receptor-mediated inhibition that accumulates because(1988) reported a similar observation for IM in frog sympa-
thetic neurons. In our study, ADP seems to substitute recovery is compromised. On the first point, we found
that normal rundown alone does not account for thefully for ATP, apparently because despite the steady
dialyzing action of the whole-cell pipette, glucose- poor recovery from inhibition seen with low-ATP solu-
tions.dependent energy metabolism readily phosphorylates
much of the added ADP to ATP within the cell. Inclusion On the second point, we favor the concept that run-
down and agonist-induced inhibition are the same pro-of ADP	S, an inhibitor of ATP regeneration (Eckstein
and Goody, 1976), together with the ADP, depressed cess. Using substitutions of adenine nucleotide analogs
and manipulations of bath glucose, Simmons andthe ability of ADP to support recovery. An analog of
GDP had a different effect. We found that putting GDP	S Schneider (1998) concluded that maintenance of IM in
neurons requires low amounts of hydrolyzable ATP.in the pipette slows the induction of inhibition dramati-
cally—presumably by reducing the probability for GTP They point out that in all reports where channels are
well maintained in the absence of pipette ATP (Simmonsto activate G proteins during receptor activation—
without affecting the recovery after removal of agonist. et al., 1990; Chen and Smith, 1992; this paper), metabolic
substrates such as glucose and/or pyruvate are in-Pfaffinger et al. (1988) also reported strong slowing of
inhibition of IM in neurons with GDP	S. All of these exper- cluded in the bath. In those studies reporting more rapid
rundown without pipette ATP (Pfaffinger et al., 1988;iments suggest that recovery requires transfer of a phos-
phate from ATP to regenerate a phosphorylated product Tokimasa and Akasu, 1990), substrates were not sup-
plied. In the Simmons and Schneider proposal, whenthat had been depleted by the preceding muscarinic
inhibition. GTP is not required during this recovery. no ATP is supplied in the pipette but metabolic sub-
strates are available, residual ADP in the cell would beWe also looked at rundown in several of the same
conditions. This is relevant from two points of view. First, phosphorylated to yield a low but nonzero ATP level.
From our work, this proposed low ATP level is insuffi-we needed to be able to show that lack of recovery after
muscarinic suppression of current is not merely due to cient to permit rapid recovery after muscarinic inhibition,
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but if significant ADP is added to the pipette solution, Several laboratories working on a variety of ion chan-
nels and transporters have provided evidence that func-it may be phosphorylated to provide enough ATP for
recovery. We suggest that the low ATP without added tions of these membrane proteins are either enhanced
or turned off by PIP2 (Hilgemann et al., 2001), and theyadenine nucleotide suffices for a low activity of lipid
kinases needed to compensate slow rundown but is have been seeking a physiological regulation that is
mediated by PIP2 breakdown or synthesis. In manyinsufficient for the major phosphorylation needed after
agonist-induced inhibition. cases, the effect of PIP2 on these membrane proteins
is documented but its physiological role and the endoge-The action of the PLC inhibitor U73122 is subtle and
requires further discussion. A previous study from this nous regulatory agonists are not yet known.
For M current modulation, the hypothesis would belaboratory showed that the mechanism of muscarinic
suppression of IM differs from that of bradykinin-induced as follows: activity of IM (and presumably all other KCNQ)
channels depends on the presence of certain phosphati-suppression (Cruzblanca et al., 1998; see also Delmas
et al., 2002). One striking difference was that muscarinic dylinositol phosphates in the membrane, including PIP2,
and activation of M1 and other Gq/11-coupled receptorssuppression was only slightly blocked by 1 M U73122
whereas bradykinin suppression was strongly blocked. suppresses current by depleting the membrane of these
essential lipid phosphates. The second messenger forThis led us to propose that PLC is not used in muscarinic
suppression of IM. Studying the muscarinic pathway in suppression of current is therefore the depletion of an
essential cofactor rather than the production of an inhib-tsA cells and SCG neurons, we now confirm the weak
effect of 1 M U73122, but find that 3 M U73122 does itor. Formally, this is analogous to vertebrate photore-
ceptors where the breakdown of cGMP is the light sig-block IM modulation. The effect is specific since the
inactive analog U73343 spares most of the muscarinic nal. Recovery then would require a sequence of
reactions that regenerate the essential lipid phosphates.suppression. Therefore, we now conclude that PLC, a
Ca2-requiring enzyme, is involved in the bradykinin and These steps would underlie the classical slow musca-
rinic regulation of IM electrical activity (Brown and Ad-muscarinic pathways alike, although the muscarinic
pathway is less sensitive to U73122. The Ca2 require- ams, 1980). Rundown of IM may also reflect gradual loss
of PIP2 from the membrane.ment would explain why the modulation of M current
fails when cytoplasmic-free Ca2 is lowered (Beech et As a test, we sought to block ATP-dependent recovery
with a panel of kinase inhibitors. Among those we tested,al., 1991).
The IC50 for U73122 is in the low micromolar range in only wortmannin and PAO worked. They totally blocked
recovery at 50 and 30 M, respectively. Wortmannin ismany assays involving PI turnover, and its effects are
concentration and time dependent. Both the 1 and the an inhibitor of PI 3-kinase at nanomolar concentrations,
and of PI 4-kinase at micromolar concentrations (Okada3M concentrations that we used should inhibit a signif-
icant fraction of the PLC, slowing but not abolishing its et al., 1994; Nakanishi et al., 1995). For blocking recovery
of current from muscarinic suppression, wortmanninactivity. This is a range of partial block of PLC. Indeed
our measurements here involve block of responses to was effective only at concentrations of 10 M. Our
20 s exposures to oxo-M, but if we lengthen the oxo-M tests of other ways to inhibit PI 3-kinase do not support
exposure to 3 min, even 3 M U73122 is insufficient to a role for them in recovery. Thus, LY 294002, a selective
prevent a slow muscarinic suppression of IM (data not inhibitor of PI 3-kinase, and expression of a dominant-
shown). Higher concentrations of U73122 were not easy negative PI 3-kinase regulatory subunit (DN p85) failed
to explore because they strongly decreased IM without to block the recovery of KCNQ2/KCNQ3 channel. Fur-
receptor stimulation. The difference between the con- thermore, PAO, an inhibitor of PI 4-kinase in vitro (Yue
centrations required to block muscarinic and bradykinin et al., 2001) and in vivo (Wiedemann et al., 1996; Linse-
actions probably reflect quantitative differences in the man et al., 1999), also inhibited recovery in a concentra-
efficiency of coupling of bradykinin and muscarinic re- tion-dependent manner. Formation of complexes with
ceptors to their effectors (Haley et al., 2000; Delmas et BAL or DTT rendered PAO inactive. These results imply
al., 2002). that the effects of lipid kinase inhibitors on recovery are
mediated by inhibiting the activity of PI 4-kinase, an
essential enzyme for the regeneration of PIP2.The Lipid Kinase and PI-Polyphosphate
Hypothesis We found that wortmannin and PAO also accelerated
rundown of channels without prior muscarinic inhibition.Receptors that activate the G proteins Gq/11, including
the M1 muscarinic receptor, turn on the activity of phos- When PI 4-kinase is inhibited, the cellular content of
PIP2 falls slowly. For example, it is reported that mem-phoinositide-specific PLC, which cleaves PIP2 into two
labile second messengers IP3 and diacylglycerol. If PLC brane PIP2 levels decrease to 20% of the control level
within 15 min in unstimulated SH-SY5Y neuroblastomais active long enough, it will deplete the membrane of
various phosphoinositides, including PIP2 and PI-4-P, cells incubated with wortmannin (Willars et al., 1998).
This would explain the gradual channel rundown in wort-faster than they are regenerated (Willars et al., 1998).
Depletion takes several seconds. Generation of more mannin and PAO.
Similarly, 30 min preincubations with wortmanninPIP2 requires a series of steps that include phosphorylat-
ing phosphatidylinositol on the inositol 4 and 5 positions were previously reported to reduce IM of bullfrog sympa-
thetic neurons (Tokimasa et al., 1995), and at that timeby lipid kinases. Regeneration of the phosphorylated
forms may take several minutes. These lipid kinases the effect was attributed to inhibition of MLCK. Wort-
mannin is indeed an inhibitor of MLCK at submicromolarrequire higher concentrations of ATP for maximal activ-
ity (1 mM) than do many protein kinases and ATP- concentrations, and previous studies provide evidence
that IM in bullfrog sympathetic ganglia can be regulateddriven reactions (a few micromolar) (Balla, 1998).
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marker for successfully transfected cells, 0.1 g of cDNA encodingby MLCK. They found that application of a peptide inhibi-
green fluorescent protein was cotransfected with channel and re-tor for MLCK decreases IM, whereas intracellular perfu-
ceptor cDNA.sion of catalytic subunits of MLCK enhances IM (Akasu SCG neurons were taken from 4- to 5-week-old male rats
et al., 1993; Tokimasa et al., 1995). Our data show that (Sprague-Dawley) and cultured for 1 day (Beech et al., 1991). Rats
applications of two specific inhibitors for MLCK, ML-7 were quickly anesthetized with CO2 and decapitated. Ganglia were
dissociated and the neurons suspended twice in DMEM supple-and ML-9, or of a nonselective MLCK inhibitor K-252a
mented with 10% heat-inactivated horse serum. Cells were plated(Nakanishi et al., 1988) neither blocked the ATP-depen-
on glass coverslips coated with poly-L-lysine, incubated at 37Cdent recovery from muscarinic inhibition nor accelerated
(5% CO2) overnight, and used within 24 hr.rundown. In addition, blockage of the known pathways
for MLCK activation using inhibitors for Ca2/calmodu-
Current Recording and Analysislin-dependent kinase and MEK had little effect on either
The whole-cell configuration of the patch-clamp technique was used
the maintenance of KCNQ2/KCNQ3 channels or the re- to voltage-clamp and dialyze cells at room temperature (22C–25C).
covery from muscarinic suppression. Thus, MLCK is not Electrodes were pulled from glass hematocrit tubes (VWR Scientific,
Seattle, WA). They had resistances of 1.3–2.5 M. The whole-celllikely to be involved in the ATP-mediated recovery of
access resistance was 2–4 M and series-resistance errors wereKCNQ2/KCNQ3 current in tsA cells.
compensated 60%. Fast and slow capacitances were compen-Here we have developed two lines of evidence consis-
sated prior to the applied test-pulse sequences. When measuringtent with the lipid-kinase hypothesis. First, recovery re-
the rates of induction and recovery from muscarinic inhibition of
quires high concentrations of hydrolyzable ATP and sec- the current, we applied test and control solutions rapidly to the 100
ond, it is blocked by inhibitors of PI 4-kinase. Additional l chamber (flow rate of 1.5 ml/min) in the vicinity of the recorded
cell. Tests using junction potential measurements on an open pipettedirect biochemical experiments and work with excised
showed that solutions are changed with a mean exponential timepatches of the type that has been successful with some
constant of 2.4 s.other channels and transporters would test these con-
The KCNQ2/KCNQ3 currents from tsA cells were studied by hold-clusions. In other examples, domains of basic residues
ing the cell at 20 mV and applying a 500 ms hyperpolarizing step
in combination with hydrophobic ones have been identi- to 60 mV every 4 s. The amplitude of the current usually was
fied as binding sites for PIP2 on the membrane protein defined as the outward current at the holding potential sensitive to
block by 30 M linopirdine. Like HEK293 cells, tsA cells do have(Fan and Makielski, 1997; Hilgemann et al., 2001). Hil-
small endogenous voltage-gated K currents (Yu and Kerchner,gemann et al. (2001) point out that in the known exam-
1998). These endogenous currents have an activation rate 10-ples of regulation by PIP2, additional signaling molecules
fold faster than KCNQ2/KCNQ3 channels, show little observable tailalso participate. Perhaps for IM PIP2 is just one of several current (deactivation) at 60 mV, and are just starting to activate
regulatory signals mediating muscarinic inhibition (see, at 20 mV (data not shown). Thus, the KCNQ2/KCNQ3 current was
for example, Cruzblanca et al., 1998). It is generally ac- distinguished easily from the endogenous current. In all experiments
with pipette solutions containing nucleotide analogs, we waitedcepted that the signal(s) for modulation of IM can diffuse
longer than 5 min before applying oxo-M to allow for the dialysisin the cytoplasm or, if in the membrane, past the seal
into the cytoplasm. The M current amplitude in SCG neurons wasof an on-cell pipette (Selyanko et al., 1992; Marrion,
measured from deactivation current records at60 mV as the differ-1993). If lipids are the signal, we will have to understand
ence between the average of a 10 ms segment, taken 10–20 ms
what component is diffusible in this manner. The case into the hyperpolarizing step, and the average during the last 10 ms
of IM stands out as one of the first recognized examples of that step.
of ion channel modulation by known physiological inputs
(Brown and Adams, 1980) and with a known physiologi- Solutions and Materials
The external Ringer’s solution used to record KCNQ currents con-cal effect on neuronal excitability. Our laboratory has
tained (in mM): 160 NaCl, 2.5 KCl, 2 CaCl2, 1 MgCl2, 10 HEPES,previously given evidence that N- and L-type Ca2 chan-
and 8 glucose, adjusted to pH 7.4 with NaOH. SCG neurons werenels can also be modulated by M1 muscarinic receptors
superfused with an external Ringer’s solution having 0.5M tetrodo-and by angiotensin II receptors using a second messen-
toxin. The standard pipette solution contained (in mM): 175 KCl,
ger pathway that may be the same as that for modulation 5 MgCl2, 5 HEPES, 0.1 1,2-bis(2-aminophenoxy)ethane N,N,N’,N’-
of IM by these receptors (Hille, 1994; Shapiro et al., tetraacetic acid (BAPTA), 3 Na2ATP, and 0.1 Na3GTP, titrated to pH
7.4 with KOH. Bisindolylmaleimide I, wortmannin, LY 294002, ML-7,1994a).
ML-9, K-252a, H-89, (S)-5-isoquinolinesulfonic acid (KN-62), AG213,
genistein, and PD 98059 were dissolved in DMSO. The final concen-Experimental Procedures
tration of DMSO never exceeded 0.3%. All other substances were
dissolved in water. Final dilutions were made with external solution.Cells
Plasmids encoding KCNQ2 (GenBank AF110020) and KCNQ3 (Gen- Reagents were obtained as follows: oxotremorine methiodide
(oxo-M) (Research Biochemicals, Natick, MA); BAPTA (MolecularBank AF091247) were kindly provided by David McKinnon (State
University of New York, Stony Brook, NY), and the plasmid con- Probes); DMEM, fetal bovine serum, lipofectamine, and penicillin/
streptomycin (Life Technologies, Gaithersburg, MD); ATP, GTP,taining mouse M1 receptor was provided by Neil Nathanson (Univer-
sity of Washington, Seattle, WA). The KCNQ2 and KCNQ3 genes GDP	S, GMP-PNP, GTPS, linopirdine, AMP-PNP, AMP-PCP,
ADP	S, ADP, wortmannin, LY 294002, KN-62, genistein, PAO, BAL,were subcloned into the pcDNA3 expression plasmid (Invitrogen,
San Diego, CA) as previously described (Shapiro et al., 2000) and DTT, Ap5A, and pirenzepine (Sigma, St. Louis, MO); ML-7, ML-9,
SB 203580, K-252a, H-89, and AG 213 (CN Biosciences, La Jolla,transiently transfected with the muscarinic M1 receptor in human
tsA-201 (tsA) cells. Cells were grown in tissue culture dishes (Falcon, CA). U73122 and U73343 were obtained from Research Biochemi-
cals. The drugs were dissolved in chloroform to a final concentrationOxnard, CA) in tsA growth medium (DMEM plus 10% fetal bovine
serum with 0.2% penicillin/streptomycin) at 37C (5% CO2) and pas- of 5 mM and aliquotted into Effendorf tubes. After evaporation of
the solvent under nitrogen, tubes were stored in 4C. On the day ofsaged approximately every 7 days. Plasmids were transfected with
lipofectamine 2000 transfection reagent (Life Technologies, Gaith- experiment, one aliquot was dissolved in dimethyl sulfoxide to a
concentration of 2.5 mM. The dominant-negative PI 3-kinase regula-ersburg, MD) according to the manufacturer’s directions. The next
day, the cells were plated onto poly-L-lysine-coated coverslip chips tory subunit p85 was kindly provided by Daniel R. Storm (University
of Washington, Seattle, WA).and used within 2 days for electrophysiological experiments. As a
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Data Analysis Eckstein, F., and Goody, R.S. (1976). Synthesis and properties of
diastereoisomers of adenosine 5
-(O-1-thiotriphosphate) and aden-Data acquisition and analysis used the Pulse/Pulse Fit 8.11 software
in combination with an EPC-9 patch clamp amplifier (HEKA, Lam- osine 5
-(O-2-thiotriphosphate). Biochemistry 15, 1685–1691.
brecht, Germany). Further data processing was performed with Ex- Fan, Z., and Makielski, J.C. (1997). Anionic phospholipids activate
cel (Microsoft) and Igor (WaveMetrics, Oregon). Time constants were ATP-sensitive potassium channels. J. Biol. Chem. 272, 5388–5395.
measured by exponential fits. All quantitative data are expressed
Haley, J.E., Abogadie, F.C., Delmas, P., Dayrell, M., Vallis, Y., Milli-
as the mean SEM. Comparison between two groups was analyzed
gan, G., Caulfield, M.P., Brown, D.A., and Buckley, N.J. (1998). The
using Student’s unpaired t test, and differences were considered
-subunit of Gq contributes to muscarinic inhibition of the M-typesignificant at a level p  0.05.
potassium current in sympathetic neurons. J. Neurosci. 18, 4521–
4531.
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